A call to action for deciphering genetic variants in human pluripotent stem cells for cell therapy

  • Nissim Benvenisty
  • , Jonathan S. Draper
  • , Paul J. Gokhale
  • , Lyn Healy
  • , Zoe Hewitt
  • , Deborah Hursh
  • , Adam Hodgson
  • , Tenneille E. Ludwig
  • , Nancy Mah
  • , Sarah E. McClelland
  • , Milena Mennecozzi
  • , Florian T. Merkle
  • , Joanne C. Mountford
  • , Martin Pera
  • , Alessandro Prigione
  • , Tristan A. Rodriguez
  • , Andrea Rossi
  • , Foad J. Rouhani
  • , Kourosh Saeb-Parsy
  • , Lucia Selfa Aspiroz
  • Nika Shakiba, Claudia Spits, Peter D. Tonge, Ivana Barbaric*
*Corresponding author for this work

Research output: Contribution to journalComment/debate

4 Scopus citations

Abstract

Human pluripotent stem cell (hPSC)-based therapies offer promise but pose potential risks due to culture-acquired genetic variants, some of which have been linked with cancer. An international workshop addressed these concerns, highlighting the need for improved strategies to stratify variants and chart a path toward definitive guidelines in hPSC-based therapy.

Original languageEnglish
Pages (from-to)508-512
Number of pages5
JournalCell Stem Cell
Volume32
Issue number4
DOIs
StatePublished - 3 Apr 2025

Bibliographical note

Publisher Copyright:
© 2025 Elsevier Inc.

Fingerprint

Dive into the research topics of 'A call to action for deciphering genetic variants in human pluripotent stem cells for cell therapy'. Together they form a unique fingerprint.

Cite this